Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Apeiron Investment Group Ltd.
Director at Enhanced · 10% owner at Faeth Therapeutics. Filing since 23 Feb 2023.
CIK 0001845711
ENHA
Enhanced Group Inc.
Director · 10 trades
FTH
Faeth Therapeutics, Inc.
10% owner · 2 trades
Company
Date
Role
Action
Shares
Amount
Of holding
ENHA
Enhanced Group Inc.
17 Sep 2026
Director
Bought
6,080,047
$6.99M
16.3%
ENHA
Enhanced Group Inc.
9 Sep 2026
Director
Bought
99,342
$159.37K
0.3%
ENHA
Enhanced Group Inc.
8 Sep 2026
Director
Bought
59,337
$93.08K
0.2%
ENHA
Enhanced Group Inc.
4 Sep 2026
Director
Bought
21,034
$33.90K
0.1%
ENHA
Enhanced Group Inc.
3 Sep 2026
Director
Bought
25,414
$40.15K
0.1%
ENHA
Enhanced Group Inc.
2 Sep 2026
Director
Bought
107,693
$169.63K
0.3%
ENHA
Enhanced Group Inc.
19 Aug 2026
Director
Bought
1,674,316
$2.78M
4.7%
ENHA
Enhanced Group Inc.
18 Aug 2026
Director
Bought
93,000
$158.21K
0.3%
ENHA
Enhanced Group Inc.
17 Aug 2026
Director
Bought
200,000
$330.42K
0.6%
ENHA
Enhanced Group Inc.
14 Aug 2026
Director
Bought
150,000
$295.62K
0.5%
FTH
Faeth Therapeutics, Inc.
1 Jun 2023
10% owner
Sold at will
3,441,661
$5.44M
100%
FTH
Faeth Therapeutics, Inc.
23 Feb 2023
10% owner
Bought
2,200
$3.54K
0.1%
12 decisions on file.
